Adaptive Biotechnologies (NASDAQ:ADPT) reported its Q4 earnings results on Tuesday, February 15, 2022 at 04:05 PM.
Here's what investors need to know about the announcement.
Earnings
Adaptive Biotechnologies beat estimated earnings by 4.44%, reporting an EPS of $-0.43 versus an estimate of $-0.45.
Revenue was up $7.75 million from the same period last year.
Past Earnings Performance
Last quarter the company beat on EPS by $0.02, which was followed by a 5.17% increase in the share price the next day.
Here's a look at Adaptive Biotechnologies's past performance:
| Quarter | Q3 2021 | Q2 2021 | Q1 2021 | Q4 2020 |
|---|---|---|---|---|
| EPS Estimate | -0.42 | -0.42 | -0.41 | -0.29 |
| EPS Actual | -0.40 | -0.35 | -0.29 | -0.33 |
| Revenue Estimate | 36.64M | 31.26M | 27.75M | 26.90M |
| Revenue Actual | 39.47M | 38.51M | 38.44M | 30.18M |
To track all upcoming earnings announcements, click to use Benzinga Earnings Calendar.
This article was generated by Benzinga's automated content engine and reviewed by an editor.
